66 related articles for article (PubMed ID: 18719620)
21. Application of pattern recognition methods to the analysis and classification of toxicological data derived from proton nuclear magnetic resonance spectroscopy of urine.
Gartland KP; Beddell CR; Lindon JC; Nicholson JK
Mol Pharmacol; 1991 May; 39(5):629-42. PubMed ID: 2034235
[TBL] [Abstract][Full Text] [Related]
22. Preclinical studies of opioids and opioid antagonists on gastrointestinal function.
Greenwood-Van Meerveld B; Gardner CJ; Little PJ; Hicks GA; Dehaven-Hudkins DL
Neurogastroenterol Motil; 2004 Oct; 16 Suppl 2():46-53. PubMed ID: 15357851
[TBL] [Abstract][Full Text] [Related]
23. Development of a home cage locomotor tracking system capable of detecting the stimulant and sedative properties of drugs in rats.
Dunne F; O'Halloran A; Kelly JP
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Oct; 31(7):1456-63. PubMed ID: 17706334
[TBL] [Abstract][Full Text] [Related]
24. Within-subject comparison of the psychopharmacological profiles of oral hydrocodone and oxycodone combination products in non-drug-abusing volunteers.
Zacny JP; Gutierrez S
Drug Alcohol Depend; 2009 Apr; 101(1-2):107-14. PubMed ID: 19118954
[TBL] [Abstract][Full Text] [Related]
25. pH-Dependent solubility and permeability criteria for provisional biopharmaceutics classification (BCS and BDDCS) in early drug discovery.
Varma MV; Gardner I; Steyn SJ; Nkansah P; Rotter CJ; Whitney-Pickett C; Zhang H; Di L; Cram M; Fenner KS; El-Kattan AF
Mol Pharm; 2012 May; 9(5):1199-212. PubMed ID: 22489626
[TBL] [Abstract][Full Text] [Related]
26. Gene expression profiling in the striatum of inbred mouse strains with distinct opioid-related phenotypes.
Korostynski M; Kaminska-Chowaniec D; Piechota M; Przewlocki R
BMC Genomics; 2006 Jun; 7():146. PubMed ID: 16772024
[TBL] [Abstract][Full Text] [Related]
27. Genetic differences in response properties of rostral ventromedial medulla neurons to the μ-opioid receptor agonist DAMGO in mouse inbred strains.
Sugino S; Namiki A; Yamakage M
Neurosci Lett; 2012 May; 517(2):107-12. PubMed ID: 22546603
[TBL] [Abstract][Full Text] [Related]
28. Three-choice drug discrimination in opioid-dependent humans: hydromorphone, naloxone and saline.
Preston KL; Bigelow GE; Bickel W; Liebson IA
J Pharmacol Exp Ther; 1987 Dec; 243(3):1002-9. PubMed ID: 2447262
[TBL] [Abstract][Full Text] [Related]
29. Improving toxicity screening and drug development by using genetically defined strains.
Festing MF
Methods Mol Biol; 2010; 602():1-21. PubMed ID: 20012389
[TBL] [Abstract][Full Text] [Related]
30. NTP Toxicology and Carcinogenesis Studies of AZT (CAS No. 30516-87-1) and AZT/alpha-Interferon A/D B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1999 Feb; 469():1-361. PubMed ID: 12579204
[TBL] [Abstract][Full Text] [Related]
31. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
EFSA GMO Panel Working Group on Animal Feeding Trials
Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
[TBL] [Abstract][Full Text] [Related]
32. Role of training dose in drug discrimination: a review.
Stolerman IP; Childs E; Ford MM; Grant KA
Behav Pharmacol; 2011 Sep; 22(5-6):415-29. PubMed ID: 21808191
[TBL] [Abstract][Full Text] [Related]
33. In Vivo Systems Response Profiling and Multivariate Classification of CNS Active Compounds: A Structured Tool for CNS Drug Discovery.
Waters S; Svensson P; Kullingsjö J; Pontén H; Andreasson T; Sunesson Y; Ljung E; Sonesson C; Waters N
ACS Chem Neurosci; 2017 Apr; 8(4):785-797. PubMed ID: 27997108
[TBL] [Abstract][Full Text] [Related]
34. In need of high-throughput behavioral systems.
Brunner D; Nestler E; Leahy E
Drug Discov Today; 2002 Sep; 7(18 Suppl):S107-12. PubMed ID: 12546875
[TBL] [Abstract][Full Text] [Related]
35. Bioinformatics and information technology: reshaping the drug discovery process.
Augen J
Drug Discov Today; 2002 Jun; 7(11):S39-40. PubMed ID: 12047878
[No Abstract] [Full Text] [Related]
36. Harnessing the informatics revolution for neuroscience drug R&D.
Manji HK; Insel TR; Narayan VA
Nat Rev Drug Discov; 2014 Aug; 13(8):561-2. PubMed ID: 25082275
[No Abstract] [Full Text] [Related]
37. Use of newer psychopharmacological drugs for pharmacological screening.
ZBINDEN G; RANDALL LO
Rev Can Biol; 1961 Jun; 20():251-9. PubMed ID: 14038121
[No Abstract] [Full Text] [Related]
38. Mining Gene Expression Data for Drug Discovery.
Pandika M
ACS Cent Sci; 2018 Aug; 4(8):944-947. PubMed ID: 30159389
[No Abstract] [Full Text] [Related]
39. Moving psychopharmacological drug development to the developing world.
Sathyanarayana Rao TS; Andrade C
Indian J Psychiatry; 2014 Apr; 56(2):105-6. PubMed ID: 24891692
[No Abstract] [Full Text] [Related]
40. Validation and implementation of a novel high-throughput behavioral phenotyping instrument for mice.
Brodkin J; Frank D; Grippo R; Hausfater M; Gulinello M; Achterholt N; Gutzen C
J Neurosci Methods; 2014 Mar; 224():48-57. PubMed ID: 24384067
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
